Verifying…
Home / Drug A–Z / Ergometrine 0.5 mg Injection_

Ergometrine 0.5 mg Injection_

NAFDAC Reg. No. A4-101315 · Drug

Registered with NAFDAC — registration activeAs of 5 November 2026 · synced automatically from official sources.
Product
Ergometrine 0.5 mg Injection_
NAFDAC number
A4-101315
Active ingredient
Ergometrine maleate
Strength
0.5 mg
Form
Injection
Pack size
10 x 1 mL ampoules
Manufacturer
Not listed
Applicant (holder)
Ugo Lab Productions (Nig). Ltd
Approved
27 May 2025
Status
Active View on NAFDAC ↗
Registration valid to
26 May 2030
WHO alerts
None found
Community reports
None
Times checked
0

RxVerify commentary

  • Ergometrine 0.5 mg Injection_ is on the NAFDAC register with an active registration (A4-101315). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. Not medical advice — always follow your doctor or pharmacist.

What Ergometrine 0.5 mg Injection_ is used for

From the official U.S. FDA label for ergometrine maleate, the active ingredient registered with NAFDAC.

What it is used for

▪ temporarily relieves: ▪ runny nose ▪ sneezing ▪ itchy, watery eyes due to hay fever ▪ itching of the nose or throat

Purpose

s Antihistamine

Do not use if

▪ to sedate a child or to make a child sleepy

Warnings

Do not use ▪ to sedate a child or to make a child sleepy Ask a doctor before use if you have ▪ trouble urinating due to an enlarged prostate gland ▪ glaucoma ▪ a breathing problem such as emphysema, or chronic bronchitis. Ask a doctor or pharmacist before use if you are ▪ taking sedatives or tranquilizers When using this product ▪ do not use more than directed ▪ drowsiness may occur ▪ avoid alcoholic drinks ▪ alcohol, sedatives, and tranquilizers may increase drowsiness ▪ be careful when driving a motor vehicle or operating machinery ▪ excitability may occur, especially in children If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. …

Pregnancy & breastfeeding

If pregnant or breast-feeding, ask a health professional before use.

General information only — not dosing advice. Always follow the leaflet in your pack and your doctor or pharmacist.

Check your pack of Ergometrine 0.5 mg Injection_

Add the expiry date printed on your pack for a full Trust Score — or look up uses, side effects and cheaper generics.

3 free checks left today · no signup Official sources: NAFDAC Green Book & recalls · WHO · U.S. FDA · NLM RxNorm

About Ergometrine 0.5 mg Injection_

What is in Ergometrine 0.5 mg Injection_?

Ergometrine 0.5 mg Injection_ contains Ergometrine maleate (0.5 mg), as injection, according to its NAFDAC registration record.

Is Ergometrine 0.5 mg Injection_ registered with NAFDAC?

Yes. Ergometrine 0.5 mg Injection_ is listed on the NAFDAC register under registration number A4-101315, and its registration is active as of 5 November 2026.

Has Ergometrine 0.5 mg Injection_ been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Ergometrine 0.5 mg Injection_ in our automatically synced alert list.

How can I check that my pack of Ergometrine 0.5 mg Injection_ is genuine?

Run a free authenticity scan with the NAFDAC number A4-101315, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

What is Ergometrine 0.5 mg Injection_ used for?

▪ temporarily relieves: ▪ runny nose ▪ sneezing ▪ itchy, watery eyes due to hay fever ▪ itching of the nose or throat (Summarised from the official U.S. FDA label for ergometrine maleate. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Ergometrine 0.5 mg Injection_? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from RxVerify users, not medical advice. Report side effects to your doctor and to NAFDAC.